Skip to main content

Table 6 Sites of initial relapse

From: Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study

Site of tumor progression

Cohort

 

300 mg/m2

400 mg/m2

500 mg/m2

No. of Patients

3

3

23

Locoregional – Infield

2

1

8

Locoregional – Outfield

2

-

-

Locoregional – Infield and Distant

1

-

3

Locoregional – Outfield and Distant

-

-

-

Distant only

-

1

4

Brain

-

-

3

Death without Progression

-

-

1